- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 12, 2025 | 4.9M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $2.43M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $3.07M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $10.84M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $11.43M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.06K |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $26.29K |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.06K |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $26.29K |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.73M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $3.54M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.73M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.54M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 2.51M sh |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$1.76M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.51 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.51 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $1.46M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $39.41K |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$1.33M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$1.5M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $2.46K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $24.05K |
| Revenue | Q1 2025 · Mar 31, 2024 | $26.5K |